Literature DB >> 17094379

High-dose methylprednisolone with chemotherapy for invasive thymoma: a case report.

Mitsutoshi Hayashi1, Manako Taira, Isao Yamawaki, Shin-Ichiro Ohkawa.   

Abstract

A case of invasive thymoma that responded well to the administration of a high-dose methylpredonisolone with cisplatin and adriamycin is reported. A 63-year-old woman was admitted to our hospital because of dyspnea, chest oppression and edema of the face. Chest CT revealed a large mass in the anterior mediastinum with the opacification of superior vena cava. Biopsy specimens from the mass revealed a spindle cell thymoma, consisting of epithelial cells and lymphoid cells. A diagnosis of invasive thymoma was made and the patient was intravenously treated with a high-dose of methylprednisolone (1000 mg on days 1-5 and 500 mg on days 6 and 7), cisplatin (80 mg/m2 on day 1) and adriamycin (40 mg/m2 on day 1). The treatment with three courses of this combined chemotherapy resulted in the improvement and regression of all clinical signs and symptoms. This case demonstrated that a high-dose methylprednisolone with cisplatin and adriamycin might be potentially effective for invasive thymoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17094379

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Spontaneous regression of symptomatic thymoma caused by infarction.

Authors:  Daijiro Hori; Shunsuke Endo; Hiroyoshi Tsubochi; Mitsuhiro Nokubi; Yasunori Sohara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-09-13

2.  Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent.

Authors:  Guoyan Qi; Peng Liu; Huimin Dong; Shanshan Gu; Hongxia Yang; Yinping Xue
Journal:  Med Sci Monit       Date:  2017-03-09

Review 3.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.